Kiniksa Pharmaceuticals, Ltd. (KNSA) financial statements (2021 and earlier)

Company profile

Business Address CLARENDON HOUSE
HAMILTON, HM11
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments233307
Cash and cash equivalents4772
Short-term investments186235
Other undisclosed current assets86
Total current assets:242314
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment66
Restricted cash and investments00
Deferred costs 0
Deferred income tax assets4
Deferred tax assets, net1
Total noncurrent assets:138
TOTAL ASSETS:255322
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2627
Accounts payable611
Accrued liabilities2016
Debt2 
Other liabilities00
Other undisclosed current liabilities 15
Total current liabilities:2843
Noncurrent Liabilities
Long-term debt and lease obligation1 
Operating lease, liability1
Liabilities, other than long-term debt00
Accounts payable and accrued liabilities 0
Other liabilities0 
Total noncurrent liabilities:10
Total liabilities:2943
Stockholders' equity
Stockholders' equity attributable to parent, including:225279
Additional paid in capital581473
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(356)(194)
Other undisclosed stockholders' equity attributable to parent00
Total stockholders' equity:225279
TOTAL LIABILITIES AND EQUITY:255322

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(170)(108)
Operating loss:(170)(108)
Nonoperating income
(Investment Income, Nonoperating)
65
Loss from continuing operations before income taxes:(164)(103)
Income tax benefit20
Net loss available to common stockholders, diluted:(162)(103)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(162)(103)
Comprehensive loss:(162)(103)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)
Comprehensive loss, net of tax, attributable to parent:(162)(103)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: